XML 35 R24.htm IDEA: XBRL DOCUMENT
v3.25.0.1

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2024
Restatement Of Previously Issued Financial Statements |
Schedule of financial statements by line items |
Schedule of financial statements by line items |  |  |  |  |  |
|  | As Reported |  | Change |  | As Restated
Indefinite life intangible assets |  | $ | 44,945,255 |  |  | $ | (34,190,000 | ) |  | $ | 10,755,255 |
Total other assets |  | $ | 210,570,510 |  |  | $ | (34,190,000 | ) |  | $ | 176,380,510 |
Total assets |  | $ | 212,279,340 |  |  | $ | (34,190,000 | ) |  | $ | 178,089,340 |
Accumulated deficit |  | $ | (274,757,816 | ) |  | $ | (34,190,000 | ) |  | $ | (308,947,816 | )
Total stockholders’ equity |  | $ | 168,595,556 |  |  | $ | (34,190,000 | ) |  | $ | 134,405,556 |
Total liabilities and stockholders’ equity |  | $ | 212,279,340 |  |  | $ | (34,190,000 | ) |  | $ | 178,089,340 |
Intangible asset impairment |  | $ | 8,421,000 |  |  | $ | 34,190,000 |  |  | $ | 42,611,000 |
Total operating expenses for the three months ended March 31, 2024 |  | $ | 17,190,840 |  |  | $ | 34,190,000 |  |  | $ | 51,380,840 |
Total operating expenses for the nine months ended March 31, 2024 |  | $ | 30,345,029 |  |  | $ | 34,190,000 |  |  | $ | 64,535,029 |
Loss from operations three months ended March 31, 2024 |  | $ | (17,190,840 | ) |  | $ | (34,190,000 | ) |  | $ | (51,380,840 | )
Loss from operations nine months ended March 31, 2024 |  | $ | (30,345,029 | ) |  | $ | (34,190,000 | ) |  | $ | (64,535,029 | )
Net loss for the three months ended March 31, 2024 |  | $ | (17,024,414 | ) |  | $ | (34,190,000 | ) |  | $ | (51,214,414 | )
Net loss for the nine months ended March 31, 2024 |  | $ | (30,728,563 | ) |  | $ | (34,190,000 | ) |  | $ | (64,918,563 | )
Comprehensive loss for the three months ended March 31, 2024 |  | $ | (15,963,213 | ) |  | $ | (34,190,000 | ) |  | $ | (50,153,213 | )
Comprehensive loss for the nine months ended March 31, 2024 |  | $ | (29,664,711 | ) |  | $ | (34,190,000 | ) |  | $ | (63,854,711 | )
Basic and diluted net loss per share for the three months ended March 31, 2024 |  | $ | (0.16 | ) |  | $ | (0.32 | ) |  | $ | (0.48 | )
Basic and diluted net loss per share for the nine months ended March 31, 2024 |  | $ | (0.39 | ) |  | $ | (0.43 | ) |  | $ | (0.82 | )
Schedule of restatement of previously issued financial statements |
Schedule of restatement of previously issued financial statements |  |  |  |  |  |
|  | As Reported |  | Change |  | As Restated
Common stock |  | $ | 14,750 |  |  | $ | 343 |  |  | $ | 15,093 |
Additional paid-in capital |  | $ | 442,304,652 |  |  | $ | 7,775,313 |  |  | $ | 450,079,965 |
Accumulated deficit |  | $ | (308,847,816 | ) |  | $ | (7,775,656 | ) |  | $ | (316,723,472 | )
Change in fair value of contingent consideration |  | $ | 486,500 |  |  | $ | (7,774,656 | ) |  | $ | (7,289,156 | )
Net loss for the three months ended March 31, 2024 |  | $ | (51,214,414 | ) |  | $ | (7,774,656 | ) |  | $ | (58,990,070 | )
Net loss for the nine months ended March 31, 2024 |  | $ | (64,918,563 | ) |  | $ | (7,774,656 | ) |  | $ | (72,694,219 | )
Comprehensive loss for the three months ended March 31, 2024 |  | $ | (50,152,213 | ) |  | $ | (7,774,656 | ) |  | $ | (57,928,869 | )
Comprehensive loss for the nine months ended March 31, 2024 |  | $ | (63,854,711 | ) |  | $ | (7,774,656 | ) |  | $ | (71,630,368 | )
Basic and diluted net loss per share for the three months ended March 31, 2024 |  | $ | (0.48 | ) |  | $ | (0.06 | ) |  | $ | (0.54 | )
Basic and diluted net loss per share for the nine months ended March 31, 2024 |  | $ | (0.82 | ) |  | $ | (0.09 | ) |  | $ | (0.91 | )

X
- References No definition available. + Details
Name: | RENB_DisclosureRestatementOfPreviouslyIssuedFinancialStatementsAbstract
Namespace Prefix: | RENB_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | RENB_ScheduleOfCondensedFinancialStatementTableTextBlock
Namespace Prefix: | RENB_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedFinancialStatementsTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration